MIRM

96.6801.23%
PR

Peter Radovich

COO & President

Mr. Peter Radovich, M.B.A. & Ph.D., serves as Independent Director at Rain Oncology Inc. (formerly known as Rain Therapeutics Inc.) since March 2018. He serves as Chief Operating Officer at Mirum Pharmaceuticals, Inc. since April 2020 and serves as its President since January 2024. Mr. Radovich served as Executive Vice President of Operations at Global Blood Therapeutics Inc. since 2019 until April 2020. He served Senior Vice President of Operations at Global Blood Therapeutics Inc. from September 1, 2016 to 2019. He served as Vice President of Program Leadership and Business Strategy at Global Blood Therapeutics, Inc. since November 2014. He has many years of biotechnology industry experience, is responsible for overseeing Global Blood's project management, chemistry, manufacturing and controls (CMC), commercial strategy and public relations functions. He possesses broad experience and success in overseeing development and commercialization programs for a number of highly regarded drugs, including Kyprolis. From 2013 to 2014, he served as Vice President of Program Leadership, Global Product Leader of Kyprolis and Senior Director at Onyx Pharmaceuticals, a subsidiary of Amgen, where he led it's global, cross-functional product team responsible for the development and commercialization of Kyprolis. He holds a BA in Biology and Chemistry from Texas Christian University and an MBA from Washington University. From 2004 to 2006, Mr. Radovich worked at Chiron Corporation (now Novartis AG), a biopharmaceutical company, in product marketing.

Positions